13D Filing: GAMCO Investors and MGC Diagnostics Corp (MGCD)

Page 16 of 16

Page 16 of 16 – SEC Filing

                                SCHEDULE II
                            INFORMATION WITH RESPECT TO
                 TRANSACTIONS EFFECTED DURING THE PAST SIXTY DAYS OR
                 SINCE THE MOST RECENT FILING ON SCHEDULE 13D (1)
                                   SHARES PURCHASED        AVERAGE
                        DATE            SOLD(-)             PRICE(2)
 COMMON STOCK-MGC DIAGNOSTICS CORP
          GABELLI & COMPANY INVESTMENT ADVISERS, INC.
                      12/28/17           29,000-           11.0300
          GAMCO ASSET MANAGEMENT INC.
                      12/28/17           37,600-           11.0300
                      12/21/17              600            10.9900
          GABELLI FUNDS, LLC.
             GABELLI VALUE PLUS TRUST PLC
                      12/28/17           90,000-           11.0300
             GABELLI GO ANYWHERE TRUST
                      12/28/17           10,000-           11.0300
             THE GDL FUND
                      12/28/17           56,837-           11.0300
                      12/20/17            3,159            10.9800
                      12/19/17            5,000            10.9800
             GABELLI ENTERPRISE M&A FUND
                      12/28/17          130,500-           11.0300
             GAMCO ALL CAP VALUE
                      12/28/17              500-           11.0300
             GABELLI ABC FUND
                      12/28/17           92,677-           11.0300
(1) UNLESS OTHERWISE INDICATED, ALL TRANSACTIONS WERE EFFECTED
    ON THE NASDAQ.
(2) PRICE EXCLUDES COMMISSION.
(3) THE TRANSACTIONS ON 12/28/17 ARE A RESULT OF THE COMPLETION OF THE
    TENDER OFFER BY ALTUS CAPITAL PARTNERS, INC. FOR ALL THE ISSUER’S
    OUTSTANDING SHARES OF COMMON STOCK.
16

Follow Mgc Diagnostics Corp (NASDAQ:MGCD)

Page 16 of 16